Abiomed

Abiomed is a health care company with the slogan "Recovering hearts. Saving lives." Founded in 1981, the company is based in Danvers, Massachusetts, United States. Abiomed, Inc., is a subsidiary of Johnson & Johnson MedTech, and it is renowned for providing innovative medical technology for circulatory support and oxygenation. Their products are designed to allow the heart to recuperate by enhancing blood flow or providing adequate oxygenation for individuals in respiratory failure.

The most recent significant investment in Abiomed was a post-IPO equity investment on 29 December 2011. This investment was made by Essex Woodlands Healthcare Partners, emphasizing the confidence placed in the company's innovative medical technology and its potential for growth and market impact.

As Abiomed continues to make strides in the field of medical technology, the company's commitment to saving lives and improving patient outcomes positions it as a key player in the health care industry, with potential for further expansion and innovation in the forthcoming years. For additional information, interested parties can visit www.abiomed.com.

It's important to note that when considering any medical technology investment, in addition to the potential for growth and innovation, ensuring safety and efficacy is paramount. Interested stakeholders should refer to the Important Safety Info provided by the company to gain comprehensive insights into their products and practices (https:\/\/bit.ly\/39kvb47).